BioCentury
ARTICLE | Company News

Sanofi acquiring vaccines company Protein Sciences

July 14, 2017 7:31 PM UTC

Sanofi (Euronext:SAN; NYSE:SNY) said it will acquire vaccines play Protein Sciences Corp. (Meriden, Conn.). The deal gives Sanofi influenza vaccine Flublok Quadrivalent, which FDA approved in October 2016.

Protein Sciences' shareholders are to receive $650 million up front and are eligible for $100 million in milestones. Sanofi expects the deal to close this quarter...

BCIQ Company Profiles

Protein Sciences Corp.

Sanofi